Other tumor entities which can show high-level INHA expression include, for example, neuroendocrine tumors of the pancreas, cholangiocarcinoma, adenocarcinoma of the lung, gastric adenocarcinoma, and clear cell renal cell carcinoma. Here, INHA is linked to clear cell renal carcinoma.